- Home
- CHRS vs IDE Comparison
CHRS vs IDE Comparison
Compare CHRS & IDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- IDE
- Stock Information
- Founded
- CHRS 2010
- IDE 2010
- Country
- CHRS United States
- IDE United States
- Employees
- CHRS 235
- IDE N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- IDE Finance/Investors Services
- Sector
- CHRS Health Care
- IDE Finance
- Exchange
- CHRS Nasdaq
- IDE Nasdaq
- Market Cap
- CHRS 134.4M
- IDE 158.5M
- IPO Year
- CHRS 2014
- IDE N/A
- Fundamental
- Price
- CHRS $1.16
- IDE $10.45
- Analyst Decision
- CHRS Strong Buy
- IDE
- Analyst Count
- CHRS 4
- IDE 0
- Target Price
- CHRS $5.38
- IDE N/A
- AVG Volume (30 Days)
- CHRS 2.4M
- IDE 33.5K
- Earning Date
- CHRS 03-12-2025
- IDE 01-01-0001
- Dividend Yield
- CHRS N/A
- IDE 8.83%
- EPS Growth
- CHRS N/A
- IDE N/A
- EPS
- CHRS N/A
- IDE N/A
- Revenue
- CHRS $304,340,000.00
- IDE N/A
- Revenue This Year
- CHRS $2.47
- IDE N/A
- Revenue Next Year
- CHRS N/A
- IDE N/A
- P/E Ratio
- CHRS N/A
- IDE N/A
- Revenue Growth
- CHRS 44.19
- IDE N/A
- 52 Week Low
- CHRS $0.66
- IDE $8.61
- 52 Week High
- CHRS $2.87
- IDE $10.46
- Technical
- Relative Strength Index (RSI)
- CHRS 38.01
- IDE 50.46
- Support Level
- CHRS $1.03
- IDE $10.10
- Resistance Level
- CHRS $1.39
- IDE $10.61
- Average True Range (ATR)
- CHRS 0.14
- IDE 0.14
- MACD
- CHRS -0.03
- IDE 0.02
- Stochastic Oscillator
- CHRS 14.04
- IDE 62.49
About CHRS Coherus BioSciences Inc.
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. The company is focused on the research, development, and commercialization of its portfolio of FDA-approved oncology products, including LOQTORZI. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company generates revenue from the United States.
About IDE Voya Infrastructure Industrials and Materials Fund of Beneficial Interest
Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.